Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Jennifer L. McQuade*, Carrie R. Daniel, Kenneth R. Hess, Carmen Mak, Daniel Y. Wang, Rajat R. Rai, John J. Park, Lauren E. Haydu, Christine Spencer, Matthew Wongchenko, Stephen Lane, Dung Yang Lee, Mathilde Kaper, Meredith McKean, Kathryn E. Beckermann, Samuel M. Rubinstein, Isabelle Rooney, Luna Musib, Nageshwar Budha, Jessie HsuTheodore S. Nowicki, Alexandre Avila, Tomas Haas, Maneka Puligandla, Sandra Lee, Shenying Fang, Jennifer A. Wargo, Jeffrey E. Gershenwald, Jeffrey E. Lee, Patrick Hwu, Paul B. Chapman, Jeffrey A. Sosman, Dirk Schadendorf, Jean Jacques Grob, Keith T. Flaherty, Dana Walker, Yibing Yan, Edward McKenna, Jeffrey J. Legos, Matteo S. Carlino, Antoni Ribas, John M. Kirkwood, Georgina V. Long, Douglas B. Johnson, Alexander M. Menzies, Michael A. Davies

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

190 Scopus citations

Fingerprint Dive into the research topics of 'Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences